Opaleye Management Inc. bought $875K of Alpha Cognition (ACOG)
Executed Feb 23, disclosed Feb 24, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Feb 24), the stock returned -2.8% (delay-adjusted); from the execution session (Feb 23), -1.2%. Derived: entry at the session's open, exit at the close 20 sessions later.
Opaleye Management Inc. (10% owner) filed 36 Form 4 reports as a reporting entity in the trailing twelve months (22 purchases, 14 sales, 3 filed past the two-business-day deadline), most often in CDXS. Across 18 priced purchase filings, the average 21-session return was +19.2% from execution and +19.4% from disclosure (delay-adjusted; derived). The largest single filing was $7.8M of HROW (197,263 sh across 3 lots, as filed), executed Mar 3.
Healthcare · Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative d…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→120,543 sh across 3 lots
Exec Sep 14
Filed Sep 16 · 5:57 PM ET ACOGPURCHASE Alpha Cognition Inc. Common Stock $400K
50,000 sh × $8.00
Exec Aug 3
Filed Aug 4 · 4:50 PM ET ACOGPURCHASE Alpha Cognition Inc. Common Stock $1.5M
190,086 sh across 2 lots
Exec Jul 22
Filed Jul 24 · 4:05 PM ET ACOGPURCHASE Alpha Cognition Inc. Common Stock $975K
152,336 sh × $6.40
Exec Jun 26
Filed Jun 29 · 4:05 PM ET ACOGPURCHASE Alpha Cognition Inc. Common Stock $149K
24,856 sh × $5.98
Exec Jun 9
Filed Jun 11 · 4:05 PM ET ACOGPURCHASE Alpha Cognition Inc. Common Stock $416K
70,577 sh × $5.90
Exec May 29
Filed May 29 · 7:21 PM ET ACOGPURCHASE Alpha Cognition Inc. Common Stock $359K
61,818 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 4:05 PM ET ACOGPURCHASE Alpha Cognition Inc. Common Stock $383K
66,411 sh across 2 lots
Exec Mar 2
Filed Mar 4 · 4:05 PM ET